World Drug Delivery and Formulation 2011

17th - 18th January 2011

Maritim ProArte Hotel Berlin, Germany

Evonik Industries Details

Evonik Industries

Company Profile:

Evonik's business line Pharma Polymers is the global industry standard with its solid oral dosage line of EUDRAGIT^® products including all regulatory and technical services along your pharma value chain. This includes the full development and support for targeted drug release. With novel melt extrusion processes we have reached a leading position in providing solubility enhancing formulations - from feasibility studies to scale-up.

Complementary to this portfolio we made critical efforts to offer enabling technologies for both, new drug development and life cycle management for existing drugs based on human barrier biology and new, proprietary functional excipients.

Key Products:

We invite you to tackle opportunities and challenges in your development pipeline.

Solubility: Our global set-up of R&D capabilities allows us to optimize difficult formulation morphologies using our process and excipients systematics. We can enter your development process at any stage. Our services span predictive modelling, feasibility studies, formulation development and optimization as well as clinical sample manufacturing. Together with partners we even support the commercial production.

Bioavailability: Drug delivery "science" obviously missed important design principles in terms of applicability. We however enable therapeutic windows for both preventive and intervention medicine based on regulatory meaningful innovations. We present new capabilities for biodegradable pharma polymers and biologicals.

Website:
www.eudragit.com